Statistics for Nektar Therapeutics (id:8279 NKTR)

Valuation metrics

Market cap

186.30M

Enterprise value

146.05M

Trailing P/E (ttm)

-0.72

Forward P/E

-1.31

PEG ratio

-1.31

Price/Sales (ttm)

2.00

Price/Book (mrq)

3.81

Enterprise Value/Revenue

1.57

Enterprise Value/EBITDA

-1.12

Overview

Shares outstanding

184.46M

Float

155.04M

Shares short

5.23M

% Held by insiders

0.01%

% Held by institutions

0.77%

Average volume (10 days)

1.67M

Average volume (90 days)

Price summary

52-Week low

0.42

52-Week high

1.93

52-Week change

57.14%

Beta

0.61

50-Day moving average

1.28

200-Day moving average

1.23

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

June 11th, 2014

Last split factor

2:1

Last split date

August 23th, 2000

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

-180.70%

Operating margin

-142.18%

Operational effectiveness

Return on assets

-22.64%

Return on equity

-161.63%

Income statement

Revenue (ttm)

0.46

Revenue per share (ttm)

0.46

Quarterly revenue growth (yoy)

Gross profit (ttm)

56.35M

EBITDA

-130,185,000.00

Net income to common (ttm)

-168,300,992.00

Diluted EPS (ttm)

-0.84

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

244.50M

Total cash per share (mrq)

1.32

Total debt (mrq)

206.09M

Total Debt/Equity (mrq)

421.59

Current ratio (mrq)

423.90%

Book value per share (mrq)

0.26

Cash flow

Cash flow statement

-176,568,992.00

Levered free cash flow (LFCF)

-74,480,248.00